April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Impact of Genes and Environment on AMD Progression
Anita Agarwal; Brian L. Yaspan; Kelly Taylor; Kylee Spencer; Lana M. Olson; Jaclyn L. Kovach; Stephen G. Schwartz; William K. Scott; Margaret A. Pericak-Vance; Jonathan L. Haines
Author Affiliations & Notes
  • Anita Agarwal
    Ophthalmology,
    Vanderbilt University, Nashville, Tennessee
  • Brian L. Yaspan
    Center for Human Genetics Research (CHGR),
    Vanderbilt University, Nashville, Tennessee
  • Kelly Taylor
    Center for Human Genetics Research (CHGR),
    Vanderbilt University, Nashville, Tennessee
  • Kylee Spencer
    Center for Human Genetics Research (CHGR),
    Vanderbilt University, Nashville, Tennessee
  • Lana M. Olson
    Center for Human Genetics Research (CHGR),
    Vanderbilt University, Nashville, Tennessee
  • Jaclyn L. Kovach
    Bascom Palmer Eye Institute, Univ of Miami Miller Sch of Medicine, Naples, Florida
  • Stephen G. Schwartz
    Bascom Palmer Eye Institute, Univ of Miami Miller Sch of Medicine, Naples, Florida
  • William K. Scott
    Human Genetics, University of Miami, Miami, Florida
  • Margaret A. Pericak-Vance
    Human Genetics, University of Miami, Miami, Florida
  • Jonathan L. Haines
    Center for Human Genetics Research (CHGR),
    Vanderbilt University, Nashville, Tennessee
  • Footnotes
    Commercial Relationships  Anita Agarwal, IP licensed to Arctic Dx (P); Brian L. Yaspan, None; Kelly Taylor, None; Kylee Spencer, None; Lana M. Olson, None; Jaclyn L. Kovach, None; Stephen G. Schwartz, Bausch and Lomb (R), Univ. of Miami (P); William K. Scott, IP licensed to Arctic Dx (P); Margaret A. Pericak-Vance, IP licensed to Arctic Dx (P); Jonathan L. Haines, IP licensed to Arctic Dx (P)
  • Footnotes
    Support  NIH Grant 7R01EY012118, NIH Center Grant P30-EY01480, Unrestricted Grant from Research to Prevent Blindness,New York, NY to Vanderbilt Uinversity, Nashville, TN and University of Miami, Miami, FL.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5239. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Impact of Genes and Environment on AMD Progression
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Anita Agarwal, Brian L. Yaspan, Kelly Taylor, Kylee Spencer, Lana M. Olson, Jaclyn L. Kovach, Stephen G. Schwartz, William K. Scott, Margaret A. Pericak-Vance, Jonathan L. Haines; Impact of Genes and Environment on AMD Progression. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5239.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To determine the impact of genetic variants and systemic risk factors on progression of early and intermediate AMD.

Methods: : We reviewed the clinical, genotype, and environmental risk factor data on the subset of patients with AMD Grades 2, 3 and 4 (early and intermediate AMD) in one or both eyes from our dataset of AMD patients. Evidence of progression or non progression of AMD grade was established by evaluating serial fundus photographs at various time intervals. Of a total of 962 AMD patients ascertained, 86 with early or intermediate AMD in one or both eyes had fundus photographs available at multiple follow up visits. Progressors (P) were defined as those who advanced by one or more grade in at least one eye. We tested unilateral and bilateral progression of AMD for univariate association with CFH Y402H, ARMS2 A69S, CFB R32Q, C3 R102G, mito4917, and including age at initial exam, gender, smoking, and body mass index (BMI) as covariates in logistic regression.

Results: : Group 1 (58 patients) had bilateral intermediate AMD, and Group 2 (28 patients) had intermediate in one eye and neovascular AMD in the fellow eye. Average followup was 3.4 years. Group 1 had 39 non progressors (NP), 11 unilateral P and 8 bilateral P. Group 2 had 17 NP and 11 P. One SNP, rs641153 in CFB was nominally associated with progression in our cohort of Caucasian individuals (p=0.04), with the bilateral progressors contributing most to the signal (p=0.069) compared to the unilateral progressors (p=0.45). Although a small cohort, it is striking that the allele frequency of the minor allele in the progressors (MAF = 0.095) is roughly 5.5x that of the non-progressors (MAF = 0.017). No other SNP approached statistical significance.

Conclusions: : In this small dataset, CFB R32Q has a suggestive risk for progression in patients with bilateral intermediate AMD. This ongoing study is prospectively recruiting patients to further evaluate these results.

Keywords: retinal degenerations: hereditary • age-related macular degeneration • genetics 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept